Lutathera® is a targeted drug therapy approved for gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that are positive for the hormone receptor somatostatin. Learn More.
Florida Cancer Specialists & Research Institute associate director Judy Wang, MD, is lead author of a manuscript on oral bacterial therapy to improve immunotherapy outcomes.
Learn the truth about sugar and cancer. Discover evidence-based nutrition guidelines and why eliminating all sugar isn’t necessary for cancer patients.
FCS Top News Updates
FCS Real-World Evidence Abstract Highlights Progress and Gaps in Biomarker Testing for Lung Cancer
FCS Study Finds Comparable Quality and Safety Outcomes in CAR T-Cell Therapy Across Accredited and Non-Accredited Centers, Highlighting Care Location as Key Driver of Patient Access and Experience
Lutathera® Treatment: What You Can ExpectLutathera® is a targeted drug therapy approved for gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that are positive for the hormone receptor somatostatin. Learn More.
FCS Expands Specialized Gynecologic Oncology ServicesMarcia Schmidt, MD, gynecologic oncologist joins Florida Cancer Specialists & Research Institute in Palm Beach County.
Judy Wang, MD is Lead Author of Manuscript Detailing Investigational Treatment to Improve Immunotherapy Outcomes for Patients with Advanced CancersFlorida Cancer Specialists & Research Institute associate director Judy Wang, MD, is lead author of a manuscript on oral bacterial therapy to improve immunotherapy outcomes.
Maen Hussein, MD Meets With King Abdullah II Ahead of UN General Assembly to Strengthen U.S.–Jordan Medical TiesDr. Hussein met with His Majesty King Abdullah II of Jordan to strengthen ties with Jordanian medical professionals working in the U.S.
Head and Neck CancerLearn more about the causes, symptoms and treatment options for head and neck cancers of the mouth, throat, larynx, nose, sinuses or salivary glands.
FCS Utilizes Proprietary Real-World Data in First Study of Treatment Response in Lower-Risk Myelodysplastic Syndrome Patients Treated with Erythropoiesis-Stimulating AgentsFlorida Cancer Specialists & Research Institute data leads to study on blood cancer being published in the Journal of Modern Economics.
Physician-Owned Practice Reinforces Commitment to Physician LeadershipFlorida Cancer Specialists & Research Institute, a physician-owned practice, reinforces its commitment to physician leadership.
Sugar and Cancer: A Myth-UnderstandingLearn the truth about sugar and cancer. Discover evidence-based nutrition guidelines and why eliminating all sugar isn’t necessary for cancer patients.